DKS Past Earnings Performance
Past criteria checks 3/6
DKS's earnings have been declining at an average annual rate of -31.1%, while the Chemicals industry saw earnings growing at 6.3% annually. Revenues have been growing at an average rate of 1.6% per year. DKS's return on equity is 1.6%, and it has net margins of 0.5%.
Key information
-31.1%
Earnings growth rate
-31.2%
EPS growth rate
| Chemicals Industry Growth | 6.6% |
| Revenue growth rate | 1.6% |
| Return on equity | 1.6% |
| Net Margin | 0.5% |
| Next Earnings Update | 14 May 2024 |
Revenue & Expenses BreakdownBeta
How DKS makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 61,617 | 287 | 7,748 | 3,236 |
| 30 Sep 23 | 61,516 | -489 | 7,836 | 3,236 |
| 30 Jun 23 | 63,524 | -982 | 8,109 | 3,236 |
| 31 Mar 23 | 65,081 | -407 | 8,198 | 3,236 |
| 31 Dec 22 | 65,073 | 237 | 8,393 | 2,946 |
| 30 Sep 22 | 65,050 | 936 | 8,297 | 2,946 |
| 30 Jun 22 | 63,700 | 2,100 | 8,028 | 2,946 |
| 31 Mar 22 | 62,672 | 2,492 | 7,730 | 2,946 |
| 31 Dec 21 | 62,457 | 2,762 | 7,603 | 2,821 |
| 30 Sep 21 | 61,515 | 2,709 | 7,517 | 2,821 |
| 30 Jun 21 | 59,921 | 2,713 | 7,426 | 2,821 |
| 31 Mar 21 | 59,140 | 2,563 | 7,424 | 2,821 |
| 31 Dec 20 | 58,691 | 2,095 | 7,974 | 2,748 |
| 30 Sep 20 | 59,069 | 2,098 | 8,039 | 2,748 |
| 30 Jun 20 | 60,023 | 2,072 | 8,252 | 2,748 |
| 31 Mar 20 | 61,456 | 2,014 | 8,491 | 2,748 |
| 31 Dec 19 | 60,967 | 2,162 | 8,275 | 2,765 |
| 30 Sep 19 | 60,535 | 2,272 | 8,225 | 2,765 |
| 30 Jun 19 | 59,984 | 2,176 | 8,140 | 2,765 |
| 31 Mar 19 | 59,574 | 2,581 | 7,955 | 2,765 |
| 31 Dec 18 | 58,608 | 2,824 | 8,194 | 2,307 |
| 30 Sep 18 | 58,322 | 3,179 | 7,975 | 2,307 |
| 30 Jun 18 | 57,915 | 3,538 | 7,698 | 2,307 |
| 31 Mar 18 | 56,955 | 3,351 | 7,453 | 2,307 |
| 31 Dec 17 | 56,299 | 3,243 | 7,262 | 2,393 |
| 30 Sep 17 | 54,559 | 2,947 | 7,133 | 2,393 |
| 30 Jun 17 | 53,252 | 2,666 | 7,158 | 2,393 |
| 31 Mar 17 | 52,254 | 2,489 | 7,096 | 2,393 |
| 31 Dec 16 | 51,419 | 2,173 | 7,158 | 2,380 |
| 30 Sep 16 | 51,436 | 2,148 | 7,139 | 2,380 |
| 30 Jun 16 | 51,849 | 2,138 | 7,116 | 2,380 |
| 31 Mar 16 | 52,782 | 2,198 | 7,063 | 2,380 |
| 31 Dec 15 | 53,835 | 2,251 | 6,973 | 2,439 |
| 30 Sep 15 | 54,665 | 1,923 | 6,919 | 2,439 |
| 30 Jun 15 | 55,607 | 1,803 | 6,779 | 2,439 |
| 31 Mar 15 | 55,597 | 1,782 | 6,679 | 2,439 |
| 31 Dec 14 | 56,182 | 1,906 | 6,555 | 2,506 |
| 30 Sep 14 | 56,165 | 1,807 | 6,590 | 2,506 |
| 30 Jun 14 | 55,235 | 1,567 | 6,477 | 2,506 |
| 31 Mar 14 | 54,614 | 1,336 | 6,480 | 2,506 |
| 31 Dec 13 | 52,724 | 948 | 6,610 | 2,340 |
| 30 Sep 13 | 51,488 | 922 | 6,403 | 2,340 |
| 30 Jun 13 | 51,384 | 816 | 6,337 | 2,340 |
Quality Earnings: 4461 has a large one-off gain of ¥369.0M impacting its last 12 months of financial results to 31st December, 2023.
Growing Profit Margin: 4461's current net profit margins (0.5%) are higher than last year (0.4%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 4461's earnings have declined by 31.1% per year over the past 5 years.
Accelerating Growth: 4461's earnings growth over the past year (21.1%) exceeds its 5-year average (-31.1% per year).
Earnings vs Industry: 4461 earnings growth over the past year (21.1%) exceeded the Chemicals industry -3.8%.
Return on Equity
High ROE: 4461's Return on Equity (1.6%) is considered low.